Panel | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
|
Panel | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||
|
Coronavirus- 2019-nCoV - COVID-19
The Coronavirus (named 2019-nCoV) emerged in Wuhan, China in December 2019. WHO declared a global health emergency on 30 January 2020, and a number of blood and tissue donor guidelines have been issued - largely based on previous guidelines for SARS-CoV and MERS-CoV. Like SARS and MERS, 2019-nCoV displayed high mortality but low infectivity in the early weeks, with limited person-to-person transmission. However, the epidemic quickly changed to display lower mortality but higher infectivity with increasing evidence of sustained person-to-person transmission.
Various public health measures taken at local or national level are likely to aid and/or complicate donor assessment, while the rapid evolution of the epidemic demands a precautionary yet flexible approach to suitability guidelines.Read more here:
- Coronavirus - 2019-nCoV recommendation from donor suitability committee.
- Information from registries whose operations are impacted by Coronavirus.
Continuity of Care during the COVID-19 crisis
WMDA wants to support continuity of care at this challenging time. Join us this week for new webinars to connect with you, our members, to give you the opportunity to connect with us and with each other as a community. Share your concerns, solutions, strategies and your ideas how to cope with this new reality we're faced with. Click on the title below to join live at the given date and time.
Tuesday, March 31 (12:00 CET): ZKRD - ensuring continuity of care and sharing their experience, by Fabian Bosbach and Carlheinz Müller
Thursday, April 2nd (12:00 CET): Italian BMDR - ensuring conrinuity of care and sharing their experience, by Nicoletta SacchiMonday, April 6th (15:00 CET): Joint webinar by EBMT and WMDA - a link and more information will follow soon
Weblinks to the daily webinars
Friday, March 27: Donor care – medical aspects
Our medical team explains the donor suitability criteria and respond to the questions you may have for donor care. Please note that we suffered a technical issue, resulting in problems with the sound during the first minutes. During the Q&A, after 9:09 minutes', the problem is solved. Find Mirjam's presentation here.
Thursday, March 26: Cord Blood Selection Service
Irina Evseeva of Anthony Nolan explains what support you will receive from the cord blood selection service and how it works. Find Irina's presentation here.
Gabi Rall of DKMS gives you an update on the work that has been done by the WMDA International Emergency Task Force and explore with you how they can support you more in the next weeks. Find Gabi's presentation here.
| How to work on WMDA Share?
| x/5wAOEw
|
Panel | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Update yourself on the latest news and read Stem Cell Matters, our monthly newsletter.
|
Panel | |||||
---|---|---|---|---|---|
|
|
In need of help? Question or suggestion?
Drop a note by e-mail tomail@wmda.info.
Read the most important updates from the WMDA office and notifications to support global collaboration. REDOME Survey Please help the Brazilian Bone Marrow Donor Registry, REDOME, by filling out their survey: here. Join the next Registry Ops & Reg Committee Meeting on 18 April, 2024 The Registry Operations and Regulation Committee will be reviewing the Global Trends Report Questionnaire. Would you like to join and give your input? Click here to register for the upcoming meeting on Thursday, 18 April from 13:00 - 14:00 CET. Find more details here. ------------------------------------------------------------------------------------------------------------------------- WMDA strongly condemns the violence that is occurring in Ukraine, Israel and Gaza. We offer our sympathies to all those who are suffering because of these conflicts. We extend our support to the donor registries and medical centres whose donors and patients are negatively affected by these crises. ------------------------------------------------------------------------------------------------------------------------- |
Panel | ||||||
---|---|---|---|---|---|---|
| ||||||